Acupuncture for patients with mild hypertension: Study protocol of an open-label multicenter randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Li, Juan ^a   Zheng, Hui ^a   Zhao, Ling ^a   Li, Ying ^a   Zhang, Yan ^a   Chang, Xiao rong ^b   Wang, Rui hui ^c   Shi, Jing ^d   Cui, Jin ^e   Huang, Yin lan ^f   Li, Xiang ^a   Chen, Jie ^a   Li, De hua ^a   Liang, Fan rong ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

^c Shanxi Institute of Chinese Medicine   (China)

^d The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine   (China)

^e GUIYANG COLLEGE OF TRADITIONAL CHINESE MEDICINE   (China)

^f NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Acupoint specificity; Acupoints effect; Acupuncture; Essential hypertension; Protocol; Randomized controlled trials

Indexed keywords

ACUPUNCTURE; ADULT; AGED; ARTICLE; BORDERLINE HYPERTENSION; CHINA; CHINESE MEDICINE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ACUPUNCTURE POINTS; ACUPUNCTURE THERAPY; ADULT; AGED; BLOOD PRESSURE; CHINA; CLINICAL PROTOCOLS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887163934     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-380     Document Type: Article

References (33)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
2. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75. 10.1161/01.HYP.0000252676.46043.18, 17159087.
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K. Heart disease and stroke statistics-2009 update a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2009, 119:480-486.
4. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol 2005, 26:478-484.
5. Liu LS. Chinese guidelines for management of hypertension. Chin J Hypertens 2010, 2011(19):701-708.
6. Wang J-G, Li Y. Characteristics of hypertension in the Chinese population. Curr Hypertens Rep 2012, 14:410-415. 10.1007/s11906-012-0288-1, 22843493.
7. Zhai Y, HU JP, Kong LZ, Zhao WH, Chen CM. Economic burden of coronary heart disease and stroke attributable to hypertension in China. Chin J Epidemiol 2006, 27:744-747.
8. Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012, 8:CD006742.
9. Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation 2001, 103:2038-2041. 10.1161/01.CIR.103.16.2038, 11319191.
10. Richter A, Herlitz J, Hjalmarson A. Effect of acupuncture in patients with angina pectoris. Eur Heart J 1991, 12:175-178.
11. Zhou W, Longhurst JC. Neuroendocrine mechanisms of acupuncture in the treatment of hypertension. Evid Based Complement Altern Med 2011, 2012:878673.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252. 10.1161/01.HYP.0000107251.49515.c2, 14656957.
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S. Guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J 2007, 2007(28):1462-1536.
14. WHO Regional Office for the Western Pacific WHO standard acupuncture point locations in the western pacific region 2008, Manila: WHO, WHO Regional Office for the Western Pacific.
15. Li Y, Zheng H, Witt CM, Roll S, Yu S-G, Yan J, Sun G-J, Zhao L, Huang W-J, Chang X. Acupuncture for migraine prophylaxis: a randomized controlled trial. Can Med Assoc J 2012, 184:401-410.
16. Zhou W, Fu L-W, Tjen-A-Looi SC, Li P, Longhurst JC. Afferent mechanisms underlying stimulation modality-related modulation of acupuncture-related cardiovascular responses. J Appl Physiol 2005, 98:872-880.
17. Zhou W, Tjen-A-Looi SC, Longhurst JC. Brain stem mechanisms underlying acupuncture modality-related modulation of cardiovascular responses in rats. J Appl Physiol 2005, 99:851-860. 10.1152/japplphysiol.01365.2004, 15817715.
18. Health Quality Ontario Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis. Ont Health Technol Assess Ser 2012, 12:1-65. Health Quality Ontario.
19. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003, 348:2407-2415. 10.1056/NEJMoa022273, 12802026.
20. Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001, 103:2579-2584. 10.1161/01.CIR.103.21.2579, 11382727.
21. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998, 32:983-988. 10.1161/01.HYP.32.6.983, 9856961.
22. Bastos J, Bertoquini S, Silva J, Polonia J. Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients. Rev Port Cardiol 2006, 25:305.
23. Fang JQ. Quality of life measurement method and application 2000, Peking University Medical Press.
24. Wang CH, Fang JQ, Tang XL, Zhang CZ, Lu YB, Meng Q, Gao L. The effect evaluation on measuring quality of life in patients with liver cancer by SF-36 scale. Tumor 2005, 25:492-494.
25. Wang CH, Fang JQ, Shi ML, Chen LY, Zhang YZ. A comparative study on measuring quality of life for drug addicts by SF-36 scale. Chin J Behav Med Sci 1998, 7:260-261.
26. Flachskampf FA, Gallasch J, Gefeller O, Gan J, Mao J, Pfahlberg AB, Wortmann A, Klinghammer L, Pflederer W, Daniel WG. Randomized trial of acupuncture to lower blood pressure. Circulation 2007, 115:3121-3129. 10.1161/CIRCULATIONAHA.106.661140, 17548730.
27. Liang F, Fang Z, Zhao L, Tang Y. Specificity of acupoint effects and its fundamental laws. Zhongguo Zhen Jiu 2009, 29:129.
28. Ding XY, She YF, Ma LX, Zhu J. Three basic characteristics of specificity of acupoint effect. China J TradiChin Medic Pharma 2010, 25:1356-1359.
29. Choi EM, Jiang F, Longhurst JC. Point specificity in acupuncture. Chin Med 2012, 7:1-5. 10.1186/1749-8546-7-1, 3275529, 22264378.
30. Zhao L, Chen J, Liu C-Z, Li Y, Cai D-J, Tang Y, Yang J, Liang F-R. A review of acupoint specificity research in china: status quo and prospects. Evid Based Complement Alter Medic 2012, 2012:543943.
31. Yin C, Seo B, Park H-J, Cho M, Jung W, Choue R, Kim C, Park H-K, Lee H, Koh H. Acupuncture, a promising adjunctive therapy for essential hypertension: a double-blind, randomized, controlled trial. Neurol Res 2007, Suppl 1:98-103.
32. Kalish LA, Buczynski B, Connell P, Gemmel A, Goertz C, Macklin EA, Pian-Smith M, Stevens S, Thompson J, Valaskatgis P. Stop hypertension with the acupuncture research program (SHARP): clinical trial design and screening results. Control Clin Trials 2004, 25:76-103. 10.1016/j.cct.2003.08.006, 14980754.
33. The National Heart, Lung, and Blood Institute Working Group on Future Directions in Hypertension Treatment Trials Major clinical trials of hypertension: what should be done next?. Hypertension 2005, 46:1-6. The National Heart, Lung, and Blood Institute Working Group on Future Directions in Hypertension Treatment Trials.